Section R388-804-5 - Diagnostic CriteriaIn diagnosing tuberculosis, health care providers shall be expected to adhere to the standards listed in this document.
(1) The Department incorporates by reference the (IDSA/ATS/CDC) diagnostic and classification standards as described in the segment entitled "Clinical Practice Guidelines: Diagnosis of Tuberculosis in Adults and Children," Clinical Infectious Diseases (2016) doi: 10.1093/cid/ciw694 First published online: December 8, 2016.(2) The Department incorporates by reference: a) "Centers for Disease Control and Prevention. Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis," MMWR 2009; 58 (01); 7-10,b) "Centers for Disease Control and Prevention. Availability of an Assay for Detecting Mycobacterium tuberculosis, Including Rifampin-Resistant Strains, and Considerations for Its Use -- United States, 2013." MMWR 2013; 62 (41), andc) National Tuberculosis Controllers Association/Association of Public Health Laboratories. "Consensus statement on the use of Cepheid Xpert MTB/RIF assay in making decisions to discontinue airborne infection isolation in healthcare settings." April 2016(3) The Department incorporates by reference the CDC diagnostic and classification standards for use of Interferon Gamma Release Assays as described in the document entitled, "Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection, United States, 2010" MMWR; 59 (no. RR-5); 1-25, 2010.Utah Admin. Code R388-804-5
Amended by Utah State Bulletin Number 2015-20, effective 9/23/2015Amended by Utah State Bulletin Number 2017-11, effective 5/11/2017Amended by Utah State Bulletin Number 2020-04, effective 2/1/2020